Synribo for Chronic Myelogenous Leukemia Approved by FDA
The US Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.
Leukemia Drug Granted Accelerated Review
The U.S. Food and Drug Administration has granted Ariad Pharmaceuticals, Inc. accelerated review of its drug ponatinib to treat patients who have chronic myeloid leukemia ( CML ) that doesn’t respond to current medications.
Cancer Goes To the Movies
If you’re familiar with Debra Winger, you may know she’s died from cancer at least a couple times – in her movies Terms of Endearment and Shadowlands . While cancer can make for heart-wrenching drama, such bleak portrayals of the disease are far from the truth.
Talking to Kids About Cancer
Nick Gonzalez is a Child Life Specialist. He talks and plays with kids who have cancer every day. These infants, toddlers, kids, adolescents and young adults come to the Dell Children’s Medical Center in Austin, Texas to be treated - mostly for leukemia, or for brain tumors or soft tissue cancers.
Helping Cancer Cells Die
One of the genes that helps to keep cancer from ever forming is the p53 gene. It works by blocking cancer cells from killing themselves. When p53 is messed up in some way, cancer cells go to town and wreak havoc.
Chronic Myelogenous Leukemia Drug Approved
Pfizer Inc. announced the US Food and Drug Administration (FDA) has approved BOSULIF (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.
New Chronic Myeloid Leukemia Drug
Chronic myeloid leukemia often responds to first-line treatment. Gleevec ( imatinib ) is the standard first-line medication. The disease usually quiets for a time, then comes back. A new drug has been approved to treat this blood and bone marrow cancer.
Monitoring the Monitoring of CML Patients
When monitored and managed properly, the outlook is quite good for people living with chronic myeloid leukemia ( CML ). There are three targeted therapies that are effective in controlling this disease. One of the keys to success is close monitoring.
New Genetic Signature for Leukemia
So what’s a genetic signature you ask? Basically it’s a set of genes in a cell that are involved in how disease starts, grows and spreads. This is hugely complicated and exciting science.
Rare Leukemia Rx Approved
Marqibo ( vincristine sulfate liposome injection) has been approved by the U.S. Food and Drug Administration to treat adults with a rare type of leukemia called Philadelphia chromosome negative ( Ph -) acute lymphoblastic leukemia (ALL).